CHEETAH - Levosimendan for Hemodynamic Support after Cardiac Surgery N Engl J Med 2017; 376:2021-2031 https://www.nejm.org/doi/full/10.10 Conclusion: In patients who required perioperative hemodynamic support after cardiac surgery, low-dose levosimendan in addition to standard care did not result in lower 30-day mortality than placebo. - Visual Abstract by Dr. Jonny Wilkinson @Wilkinsonjonny #Levosimendan #VisualAbstract #CHEETAH #EBM #Cardiac #Thoracic #Surgery